COMMUNIQUÉS West-GlobeNewswire

Endocyte Announces Presentations at the American Chemical Society (ACS) National Meeting & Exposition
17/08/2018
WEST LAFAYETTE, Ind., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that two posters will [...]
Evolus Granted Approval of DWP-450 by Health Canada
17/08/2018
IRVINE, Calif., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced that Health Canada has granted approval of DWP-450 (prabotulinumtoxinA) for the [...]
Delcath Issues Letter to Stockholders
17/08/2018
NEW YORK, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH) (“Delcath” or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, [...]
The American Health Council Appoints Nicholas Avitabile, MD to Board of Physicians
17/08/2018
NEW YORK, Aug. 17, 2018 (GLOBE NEWSWIRE) -- The American Health Council appointed Nicholas Avitabile, MD to its Board of Physicians for his outstanding contributions to the medical field. An endocrinologist at Crystal [...]
Precipio Announces Second Quarter 2018 Financial Results and Provides Corporate Update
17/08/2018
Conference call with management to be held Thursday August 23, 2018 at 09:00 Eastern Time NEW HAVEN, Conn., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), has [...]
Emergent BioSolutions to Participate in Series of Near-Term Investor Conferences
17/08/2018
GAITHERSBURG, Md., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences [...]
Akari Announces First Quarter 2018 Financial Results and Update on its Growing Pipeline of Phase II and Phase III Clinical Trials
17/08/2018
Opened three clinical trials in 2018 Trials in which complement dysregulation is the primary disease driver CAPSTONE, the Phase III trial in naïve paroxysmal nocturnal hemoglobinuria (PNH), in which patient treatment [...]
C-RAD AB – Interim report January-June 2018
17/08/2018
C-RAD AB – Interim report January-June 2018 PROFITABLE QUARTER, REVENUE INCREASED BY 61 PERCENT SECOND QUARTER 2018 Order intake: 56.4 (49.3) MSEK, 14%. Revenues: 51.9 (32.2) MSEK, 61%. Operating profit: 2.0 (-4.1) MSEK [...]
Immunicum AB (publ) Interim Report April - June 2018
17/08/2018
Press Release 17 August 2018 Immunicum AB (publ) Interim Report April - June 2018 Significant Events During the Second Quarter Immunicum announced Publication of Scientific Review of Ilixadencel Approach in [...]
Terveystalo Plc: Terveystalo Group Half-Year Report January 1-June 30, 2018
17/08/2018
Terveystalo Plc Half-Year Report 17 August 2018 at 9:00 a.m. EEST Strong bottom line growth continued. Strengthened balance sheet supports preparations for the Attendo acquisition. Highlights of the second quarter, [...]
Motif Bio to Present Iclaprim Data at ESCMID/ASM Conference
17/08/2018
NEW YORK, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that iclaprim data will be presented [...]
Shire plc: Rule 2.9 Announcement
17/08/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 17 August 2018 [...]
HitGen Announces Innovative Drug Discovery Research Collaboration with LG Chem by Applying DNA-Encoded Technology
17/08/2018
CHENGDU, China, Aug. 17, 2018 (GLOBE NEWSWIRE) -- HitGen Ltd today announced a multi-year major drug discovery research collaboration with LG Chem to identify novel small molecule leads for targets of interest. In this [...]
Krystal Biotech Announces $10 Million Private Placement with Frazier Healthcare Partners
17/08/2018
PITTSBURGH, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech , Inc. (Nasdaq: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological [...]
Agility Health Announces Private Placement, Engages FronTier Flex Marketing and Grants Stock Options
17/08/2018
HAMILTON, Ontario, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Not for distribution to United States Newswire Services or for dissemination in the United States Agility Health, Inc. (TSXV: AHI) (“ Agility Health ” or, the “ [...]
Antares Pharma Announces FDA Approval of Generic EpiPen Utilizing VIBEX Auto Injector
16/08/2018
Teva’s Epinephrine Auto Injector Product Deemed AP Rated and Fully Substitutable at the Pharmacy EWING, N.J., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) today announced that the U. [...]
Immunomedics to Report Fourth Quarter and Fiscal Year 2018 Results and Host Conference Call and Webcast on August 23, 2018
16/08/2018
MORRIS PLAINS, N.J., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
Teligent Secures Critical Supply during Canadian National Drug Crisis despite Worldwide Shortage
16/08/2018
TORONTO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Teligent , Inc. (NASDAQ:TLGT) (“Teligent”), a specialty generic pharmaceutical company, averted a national sterile water and sodium chloride crisis by securing inventory to [...]
Inspire Medical Systems, Inc. to Present at the 13th Annual Wells Fargo Securities Healthcare Conference
16/08/2018
MINNEAPOLIS, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

Pages